aTyr Pharma Inc. (ATYR)
NASDAQ: ATYR
· Real-Time Price · USD
4.90
-0.09 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
4.90
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
-1.80% (1D)
Bid | 4.83 |
Market Cap | 480.13M |
Revenue (ttm) | n/a |
Net Income (ttm) | -63.41M |
EPS (ttm) | -0.79 |
PE Ratio (ttm) | -6.2 |
Forward PE | -8.65 |
Analyst | Buy |
Ask | 4.97 |
Volume | 3,992,281 |
Avg. Volume (20D) | 4,093,822 |
Open | 4.95 |
Previous Close | 4.99 |
Day's Range | 4.71 - 4.97 |
52-Week Range | 1.67 - 7.29 |
Beta | 0.95 |
About ATYR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATYR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATYR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
aTyr Pharma Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+11.14%
ATyr Pharma shares are trading higher after Leerin...
Unlock content with
Pro Subscription
10 months ago
+7.47%
aTyr Pharma shares are trading higher after Wells Fargo initiated coverage on the stock with an Overweight rating and announced a price target of $17.